FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

25964511000001108: Trametinib 2mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Sep 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
83031501000001114 Trametinib 2mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
83031601000001113 Trametinib 2mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trametinib 2mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Trametinib 2mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Trametinib 2mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Trametinib 2mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Trametinib 2mg tablets Has active ingredient Trametinib false Inferred relationship Existential restriction modifier
Trametinib 2mg tablets Is a Trametinib true Inferred relationship Existential restriction modifier
Trametinib 2mg tablets Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Trametinib 2mg tablets Is a Trametinib false Inferred relationship Existential restriction modifier
Trametinib 2mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Trametinib 2mg tablets Has specific active ingredient Trametinib false Inferred relationship Existential restriction modifier
Trametinib 2mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Trametinib 2mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Trametinib 2mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Trametinib 2mg tablets Has specific active ingredient Trametinib true Inferred relationship Existential restriction modifier
Trametinib 2mg tablets Has active ingredient Substance with protein-tyrosine kinase inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Trametinib 2mg tablets Is a Product containing trametinib false Inferred relationship Existential restriction modifier
Trametinib 2mg tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mekinist 2mg tablets (Imported (United States)) Is a True Trametinib 2mg tablets Inferred relationship Existential restriction modifier
Trametinib 2mg tablets 30 tablet Has VMP True Trametinib 2mg tablets Inferred relationship Existential restriction modifier
Mekinist 2mg tablets (Novartis Pharmaceuticals UK Ltd) Is a True Trametinib 2mg tablets Inferred relationship Existential restriction modifier
Trametinib 2mg tablets 7 tablet Has VMP True Trametinib 2mg tablets Inferred relationship Existential restriction modifier
Mekinist 2mg tablets (Originalis B.V.) Is a True Trametinib 2mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start